Cargando…
Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment
Mandibuloacral dysplasia type A (MADA) is a rare laminopathy characterized by growth retardation, craniofacial anomalies, bone resorption at specific sites including clavicles, phalanges and mandibula, mottled cutaneous pigmentation, skin rigidity, partial lipodystrophy, and insulin resistance. The...
Autores principales: | Camozzi, Daria, D’Apice, Maria Rosaria, Schena, Elisa, Cenni, Vittoria, Columbaro, Marta, Capanni, Cristina, Maraldi, Nadir M., Squarzoni, Stefano, Ortolani, Michela, Novelli, Giuseppe, Lattanzi, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432780/ https://www.ncbi.nlm.nih.gov/pubmed/22706480 http://dx.doi.org/10.1007/s00418-012-0977-5 |
Ejemplares similares
-
Rapamycin treatment of Mandibuloacral Dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics
por: Cenni, Vittoria, et al.
Publicado: (2014) -
Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution
por: Capanni, Cristina, et al.
Publicado: (2012) -
Diverse lamin-dependent mechanisms interact to control chromatin dynamics: Focus on laminopathies
por: Camozzi, Daria, et al.
Publicado: (2014) -
Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria
por: Cenni, V., et al.
Publicado: (2011) -
Erratum - Autophagic Degradation of Farnesylated Prelamin a as a Therapeutic Approach to Lamin-Linked Progeria
por: Cenni, V., et al.
Publicado: (2013)